| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6af326e5335e49250f6c46160b7eb48 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate |
2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ee2f2166219a7046308bd07e863abf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfba28026291188448700926cffe6a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8476e49e4a293440c7a36af8e74aa57c |
| publicationDate |
2014-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140085880-A |
| titleOfInvention |
Markers for predicting survival and the response to anti-cancer drug in a patient with lung cancer |
| abstract |
The present invention relates to a marker for predicting the response and survival prognosis of cancer patients in lung cancer patients using gene polymorphisms and their use. More specifically, the present invention relates to a method for predicting survival prognosis of lung cancer by identifying a specific single nucleotide polymorphism (SNP) base having a significant correlation with the response to anticancer drugs and the prediction of survival prognosis in lung cancer patients, The present invention relates to a composition for predicting the reactivity and survival prognosis of an anticancer agent in a lung cancer patient comprising a polynucleotide, a polypeptide or a cDNA thereof, and a microarray and a kit comprising the same. |
| priorityDate |
2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |